The DOI matches its Crossref record; 73 of the 77 references it cites were found in a registry or an index.
NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK
Open accessAbstract
Constitutively activated NF-kappaB occurs in many inflammatory and tumor tissues. Does it interfere with anti-inflammatory or anti-tumor signaling pathway? Here, we report that NF-kappaB p65 subunit repressed the Nrf2-antioxidant response element (ARE) pathway at transcriptional level. In the cells where NF-kappaB and Nrf2 were simultaneously activated, p65 unidirectionally antagonized the transcriptional activity of Nrf2. In the p65-overexpressing cells, the ARE-dependent expression of heme oxygenase-1 was strongly suppressed. However, p65 inhibited the ARE-driven gene transcription in a way that was independent of its own transcriptional activity. Two mechanisms were found to coordinate the p65-mediated repression of ARE: (1) p65 selectively deprives CREB binding protein (CBP) from Nrf2 by competitive interaction with the CH1-KIX domain of CBP, which results in inactivation of Nrf2. The inactivation depends on PKA catalytic subunit-mediated phosphorylation of p65 at S276. (2) p65 promotes recruitment of histone deacetylase 3 (HDAC3), the corepressor, to ARE by facilitating the interaction of HDAC3 with either CBP or MafK, leading to local histone hypoacetylation. This investigation revealed the participation of NF-kappaB p65 in the negative regulation of Nrf2-ARE signaling, and might provide a new insight into a possible role of NF-kappaB in suppressing the expression of anti-inflammatory or anti-tumor genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, decreased levels of Nrf2, a transcription factor negatively regulated by NF-κB (Liu et al., 2008) that is involved in antioxidants response mechanisms (Nair et al., 2008), have been reported in the brains of AD patients (Ramsey et al., 2007).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Liu et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade
Suzawa, M., Takada, I., Yanagisawa, J., Ohtake, F., Ogawa, S., Yamauchi, T., Kadowaki, T., Takeuchi, Y., Shibuyà, H., Gotoh, Y., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb942 · Cited by 292
RetractedHayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 1×
“Nrf2 is amember of theCNC-basic leucine zipper (CNC-bZIP) family of transcription factors, which coordinately regulates the constitutive and inducible expression of antioxidant and phase 2 detoxification enzymes, such as heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase 1 (NQO1), via a cis-acting DNA element…”
BackgroundNF-κB activation by reactive oxygen species: Fifteen years later
Gloire, G., Legrand-Poels, S., & Piette, J. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,561
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,284
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L., Fischle, W., Verdin, E. M., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,231
Persistent oxidative stress in cancer
Toyokuni, S., Okamoto, K., Yodoi, J., & Hiai, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01368-b · Cited by 1,219
Flagged first, then by citations
4 of the 77 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 699
Yue, Z., Zhang, Y., Zhang, W., Zheng, N., Wen, J., Ren, L., Rong, X., Bai, L., Wang, R., Zhao, S., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.10.037 · Cited by 42
“HDAC3 can also regulate the nuclear factor-kappa B (NF-j B) to repress the activities of antioxidant enzymes and Nrf2 transcriptional activity at antioxidant response elements, thereby aggravating the tissue damage of myocardial infarction [18,19].”
Navarro, E., & Esteras, N. (2024) · Antioxidants · doi:10.3390/antiox13121502 · Cited by 48
“In addition, NF-κ B can also inhibit or prevent Nrf2 induction by several mechanisms including the competition with the coactivator CBP or recruiting HDAC3, which promotes histone hypoacetylation and impedes Nrf2 signalling [83].”
Clinically approved CFTR modulators rescue Nrf2 dysfunction in cystic fibrosis airway epithelia
Borcherding, D. C., Siefert, M. E., Lin, S., Brewington, J. J., Sadek, H. A., Clancy, J. P., Plafker, S. M., & Ziady, A. G. (2019) · Journal of Clinical Investigation · doi:10.1172/jci96273 · Cited by 42
Liu, M., Zhang, C., Xu, X., Zhao, X. S., Han, Z., Liu, D., Bo, R., Li, J., & Liu, Z. (2021) · Veterinary Research · doi:10.1186/s13567-021-00973-3 · Cited by 43
“In addition, Nrf2 and NF-κB competitively bind to the transcriptional coactivator cAMP-response-elementbinding protein-binding protein (CBP) in the nucleus, playing opposite roles in regulating the expression of inflammatory genes [21, 22].”
BackgroundAlves, I., Araújo, E. M. Q., Dalgaard, L. T., Singh, S. P., Børsheim, E., & Carvalho, E. (2025) · Nutrients · doi:10.3390/nu17030428 · Cited by 45
Li, Z., Feng, H., Han, L., Ding, L., Shen, B., Tian, Y., Zhao, L., Jin, M., Wang, Q., Qin, H., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14935 · Cited by 41
Siraj, M. A., Islam, M. A., Fahad, M. A. A., Kheya, H. R., Xiao, J., & Simal‐Gándara, J. (2021) · Applied Sciences · doi:10.3390/app112210806 · Cited by 46
Wang, Y., Zhang, X., Meng, F.-G., & Zeng, T. (2021) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2021.1894624 · Cited by 40
Ajibare, A. J., Odetayo, A. F., Akintoye, O. O., & Olayaki, L. A. (2024) · Redox Report · doi:10.1080/13510002.2024.2341537 · Cited by 40
“Interest-ingly, overexpression of NFκB inhibits the transcriptional activity of Nrf2, thereby leading to oxidative stress [41].”
BackgroundRole of NRF2 in Pathogenesis of Alzheimer’s Disease
Chu, C., Uruno, A., Katsuoka, F., & Yamamoto, M. (2024) · Antioxidants · doi:10.3390/antiox13121529 · Cited by 43
Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells
Weijer, R., Broekgaarden, M., van Golen, R. F., Bulle, E., Nieuwenhuis, E. A., Jongejan, A., Moerland, P. D., van Kampen, A. H. C., van Gulik, T. M., & Heger, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1994-2 · Cited by 44
“It has been proposed that RELA, a subunit of NF-κB, interferes with NFE2L2 activation through deprivation of CREB binding protein (CREBBP) and activation of histone deacetylase 3 (HDAC3) [34].”
BackgroundXu, X., Zhang, X., Zhang, Y., Yang, L., Liu, Y., Huang, S., Lu, L., Kong, L., Li, Z., Guo, Q., et al. (2017) · Scientific Reports · doi:10.1038/srep39950 · Cited by 40
RetractedChen, X.-Y., Dou, Y., Luo, D.-D., Zhang, Z., Li, C.-L., Zeng, H.-F., Su, Z.-R., Xie, J.-H., Lai, X., & Li, Y.-C. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.001 · Cited by 38
Trellu, S., Courties, A., Jaisson, S., Gorisse, L., Gillery, P., Kerdine‐Römer, S., Vaamonde‐García, C., Houard, X., Ekhirch, F.-P., Sautet, A., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1801-y · Cited by 40
“Mann GE, David JR, Li FYL, de Winter P, Siow RC. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf-2-mediated antioxidant gene expression.”
BackgroundInfluentialHu, B., Wei, H., Song, Y., Chen, M., Fan, Z., Qiu, R., Zhu, W., Xu, W., & Wang, F. (2020) · Journal of Virology · doi:10.1128/jvi.00016-20 · Cited by 40
“In addition, the nuclear export sequence (NES) in Keap1 is required for termination of Nrf2-ARE signaling via nuclear export of Nrf2, resulting in the degradation of Nrf2 (24).”
BackgroundInfluentialNajjar, R. S., & Feresin, R. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041668 · Cited by 42
Ryu, J., Kwon, M.-J., & Nam, T.-J. (2015) · Marine Drugs · doi:10.3390/md13084721 · Cited by 39
“However, HO-1 inhibition blocked LPS and proinflammatory cytokines-stimulated iNOS expression and NO production [15].”
BackgroundTian, S., Zhao, H., & Song, H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2148090 · Cited by 42
“Various studies demonstrated that Nrf2-mediated enzymes such as glutathione peroxidase 1 (GPx-1), heme oxygenase-1 (HO-1), and NAD (P) H: quinone oxidoreductase 1 (NQO-1) have a marked increase when the Keap1-Nrf2-ARE cascade is activated (Li et al. 2016).”
BackgroundInfluentialProthymosin α overexpression contributes to the development of pulmonary emphysema
Su, B., Tseng, Y., Shieh, G.-S., Chen, Y.-C., Shiang, Y.-C., Wu, P., Li, K.-J., Yen, T.-H., Shiau, A., & Wu, C. (2013) · Nature Communications · doi:10.1038/ncomms2906 · Cited by 39
Lee, E.-S., Yin, Z., Sidoryk‐Wȩgrzynowicz, M., Jiang, H., & Aschner, M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.016 · Cited by 39
“When 15 d-PGJ2 increases Nrf2 activation, it would deprive NF-κB p65 of CBP, which is required for the activation of the NF-κB pathway, thus resulting in the inhibition of NF-κB activation.”
BackgroundInfluentialPantan, R., Tocharus, J., Suksamrarn, A., & Tocharus, C. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.02.017 · Cited by 39
Li, C., Chen, T., Zhou, H., Zhang, C., Feng, Y., Tang, F., Hoi, M. P. M., He, C., Zheng, Y., & Lee, S. M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491059 · Cited by 40
Wang, Z., Han, G., Liu, Q., Zhang, W., & Wang, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9388 · Cited by 39
Protective role of NRF2 in macrovascular complications of diabetes
Wu, J., Sun, X., Jiang, Z., Jiang, J., Xu, L., Tian, A., Sun, X., Meng, H., Li, Y., Huang, W., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15583 · Cited by 39
Scuto, M. C., Modafferi, S., Rampulla, F., Zimbone, V., Tomasello, M., Spanò, S. M., Ontario, M. L., Palmeri, A., Salinaro, A. T., Siracusa, R., et al. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111686 · Cited by 40
Khassafi, N., Tameh, A. A., Mirzaei, H., Rafat, A., Barati, S., Khassafi, N., & Vahidinia, Z. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114655 · Cited by 38
Zhu, Z., Ding, J., Qin, M., Wang, L., Jiang, D., Zhao, J., Wang, D., & Jia, W. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303229 · Cited by 40
Marques, O., Horvat, N. K., Zechner, L., Colucci, S., Sparla, R., Zimmermann, S., Neufeldt, C. J., Altamura, S., Qiu, R., Müdder, K., et al. (2024) · Blood · doi:10.1182/blood.2023023417 · Cited by 55
Molecular mechanisms of lipopolysaccharide-mediated inhibition of glutathione synthesis in mice
Tomasi, M. L., Ryoo, M., Yang, H., Iglesias–Ara, A., Ko, K. S., & Lu, S. C.-L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.018 · Cited by 38
“The primers and TaqMan probes for murine Gclc, Gclm, GS, ubiquitin-conjugating enzyme 9 (Ubc9), SUMO-1,2,3, p65, MafG, MafF, MafK and the Universal PCR Master Mix were purchased from Applied Biosystems (Foster City, CA).”
BackgroundInfluentialYang, L., Qu, M., Wang, Y., Duan, H., Chen, P., Wang, Y., Shi, W., Danielson, P., & Zhou, Q. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.081059 · Cited by 40
“TSA-induced Nrf2 activation may be related to the acetylation state of Nrf2 or changed acetylation levels of histones that are local to the antioxidant response element–binding sites (Liu et al., 2008; Sun et al., 2009).”
BackgroundGiusti, L., Gabriele, M., Penno, G., Garofolo, M., Longo, V. G., Prato, S. D., Lucchesi, D., & Pucci, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1026268 · Cited by 39
Dihingia, A., Ozah, D., Baruah, P. K., Kalita, J., & Manna, P. (2017) · Food & Function · doi:10.1039/c7fo01491k · Cited by 38
Yang, H.-M., Zhuo, J.-Y., Sun, C., Nie, J., Yuan, J., Liu, Y., Lin, R.-F., Lai, X., Su, Z., & Li, Y. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.029 · Cited by 38
Lu, M., Shao, H.-L., Liu, T., You, Q., & Jiang, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112734 · Cited by 38
Farfán, N., Carril, J., Redel, M., Zamorano, M., Araya, M., Monzón, E., Alvarado, R., Contreras, N., Tapia-Bustos, A., Quintanilla, M. E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207800 · Cited by 41
“The antagonism exerted by NRF2 on p65 translocation has been described in cancer cells, showing that simultaneous activation of p65 and NRF2 antagonize each other by competing for the co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)-p300 complex, leading to inhibition of the NRF2 pathway…”
BackgroundNunes, C., Teixeira, N., Serra, D., de Freitas, V. A. P., Almeida, L. M., & Laranjinha, J. A. N. (2015) · Toxicology Research · doi:10.1039/c5tx00214a · Cited by 37
Delayed Nrf2-regulated antioxidant gene induction in response to silica nanoparticles
Zhang, H., Zhou, L., Yuen, J., Birkner, N. R., Leppert, V. J., O’Day, P. A., & Forman, H. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.002 · Cited by 37
Dithiolethiones: A Privileged Pharmacophore for Anticancer Therapy and Chemoprevention
Ansari, M. I., Khan, M. M., Saquib, M., Khatoon, S., & Hussain, M. K. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0281 · Cited by 37
Haghani, A., Cacciottolo, M., Doty, K. R., D’Agostino, C., Thorwald, M. A., Safi, N., Levine, M. E., Sioutas, C., Town, T., Forman, H. J., et al. (2020) · eLife · doi:10.7554/elife.54822 · Cited by 40
“In contrast, NFKB can also inhibit NRF2 activity through enhancing the recruitment of histone deacetylase (HDAC3) to ARE region (Wakabayashi et al., 2010), or competing with NRF2 for binding to CH1-KIX domain of CBP protein inside the nucleus (Liu et al., 2008).”
BackgroundWan, F. J., Tang, L., Rao, G., Zhong, G., Jiang, X., Wu, S., Huang, R., Tang, Z., Ruan, Z., Chen, Z., et al. (2022) · Toxicon · doi:10.1016/j.toxicon.2022.01.010 · Cited by 37
Dicarbonyl Stress in Diabetic Vascular Disease
Stratmann, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116186 · Cited by 38
“NF-κB antagonises the transcriptional activity of Nrf2; therefore, hyperglycaemiadriven or an inflammation-associated increase in NF-κB accounts for the reduced GLO1 expression [8].”
BackgroundLaurindo, L. F., de Maio, M. C., Minniti, G., Corrêa, N. D. G., Barbalho, S. M., Quesada, K. R., Guiguer, É. L., Sloan, K. P., Detregiachi, C. R. P., Araújo, A. C., et al. (2023) · Metabolites · doi:10.3390/metabo13020243 · Cited by 38
Stevioside attenuates osteoarthritis via regulating Nrf2/HO-1/NF-κB pathway
Wu, J., Li, H., Hu, F., & Luo, P. (2022) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2022.05.005 · Cited by 36
Mehranfard, N., Ghasemi, M., Rajabian, A., & Ansari, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22820 · Cited by 40
Zhang, Y., Zhang, W., Zhao, Y., Peng, R., Zhang, Z., Xu, Z., Simal‐Gándara, J., Yang, H., & Deng, J. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2354937 · Cited by 36
“Additionally, NF-κB can negatively regulate Nrf2-ARE signaling, with the overexpression of the NF-κB p65 subunit participating in this regulation (Liu, Qu, and Shen 2008).”
Protection by DHA of Early Hippocampal Changes in Diabetes: Possible Role of CREB and NF-κB
Álvarez-Nölting, R., Arnal, E., Barcia, J. M., Miranda, M., & Romero, F. J. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0588-x · Cited by 38
“It was reported recently that NFjB could directly repress Nrf2 signaling at the transcription level [21].”
BackgroundInfluentialModulation of diabetes-related liver injury by the HMGB1/TLR4 inflammatory pathway
Stojanov, S. J., Martinović, V., Bogojević, D., Poznanović, G., Petrović, A., Ivanović‐Matić, S., & Grigorov, I. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0626-0 · Cited by 36
“of CAT whose gene transcription is primarily regulated by Nrf2 [24].”
BackgroundPietro, C. D., Öz, H. H., Murray, T. S., & Bruscia, E. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01059 · Cited by 36
“Some of these conflicting data can be reconciled by the complex NF-kB crosstalk with Nrf2 in modulating HO-1 induction during specific cellular responses (Liu et al., 2008; Yu et al., 2011).”
BackgroundYassin, N. Y. S., AbouZid, S. F., El-Kalaawy, A. M., Ali, T. M., Elesawy, B. H., & Ahmed, O. M. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7665169 · Cited by 36
“It has been proved that NF-κB competes with Nrf2 for transcription coactivator CREB binding protein (CBP) and can directly suppress the transcriptional level of Nrf2 [84].”
BackgroundPhelps, D. S., Umstead, T. M., Quintero, O. A., Yengo, C. M., & Floros, J. (2011) · Proteome Science · doi:10.1186/1477-5956-9-67 · Cited by 37
“However, the interaction between NF- B and Nrf2 is complex and may vary in different systems or under different circumstances [138].”
BackgroundTargeting Nrf2 and NF-κB Signaling Pathways in Cancer Prevention: The Role of Apple Phytochemicals
Gado, F., Ferrario, G., Vedova, L. D., Zoanni, B., Altomare, A., Carini, M., Aldini, G., D’Amato, A., & Baron, G. (2023) · Molecules · doi:10.3390/molecules28031356 · Cited by 35
NRF2 in age-related musculoskeletal diseases: Role and treatment prospects
Zhang, X., Li, H., Chen, L., Wu, Y., & Li, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101180 · Cited by 38
“40 In the case of inflammation, NRF2 also has another mechanism with NF-k B. Studies have shown that up-regulation of NRF2 can enhance the clearance of a -synuclein, which is a proinflammatory protein promoting the activation of NF-k B, to reduce inflammation.”
BackgroundAnsari, N., Khodagholi, F., Amini, M., & Shaerzadeh, F. (2011) · Biochimie · doi:10.1016/j.biochi.2011.01.012 · Cited by 35
Bixin protects against particle-induced long-term lung injury in an NRF2-dependent manner
Xue, L., Zhang, H., Zhang, J., Li, B., Zhang, Z., & Tao, S. (2018) · Toxicology Research · doi:10.1039/c7tx00304h · Cited by 35
Lukić, I., Mitić, M., Djordjevic, J., Tatalović, N., Bozovic, N., Soldatović, I., Mihaljevic, M. M., Pavlović, Z., Radojcic, M. B., Marić, N. P., et al. (2014) · Neuropsychobiology · doi:10.1159/000362841 · Cited by 37
Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents
Lu, C., Wei, J., Gao, C., Sun, M., Dong, D., & Mu, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113373 · Cited by 37
The Attenuation of Chronic Ulcerative Colitis by (R)‐salbutamol in Repeated DSS‐Induced Mice
Deng, L., Guo, H., Wang, S., Liu, X., Lin, Y., Zhang, R., & Tan, W. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9318721 · Cited by 34
“Furthermore, CREB binding protein (CBP) is a transcription factor between Nrf-2 and NF-κB, which means that there is competition betweenNrf-2 and NF-κB, namely, negative feedback regulation [48].”
BackgroundZhang, P., Jin, Y., Xia, W., Wang, X., & Zhou, Z. (2023) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2023.03.002 · Cited by 34
Varady, J., Eder, K., & Ringseis, R. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0181-8 · Cited by 36
Jain, R., Vora, L. K., Nathiya, D., & Khatri, D. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05389-0 · Cited by 36
“Interference between p65 and Nrf2 diminishes the ability of cells to neutralize ROS and cause oxidative damage [128].”
Need (more than) two to Tango: Multiple tools to adapt to changes in oxygen availability
Fratantonio, D., Cimino, F., Speciale, A., & Virgili, F. (2018) · BioFactors · doi:10.1002/biof.1419 · Cited by 34
“Its transcriptional activity can be triggered by many different stimuli, including bacterial lipopolysaccharide (LPS), viral pathogens, cytokines, or growth factors [114].”
BackgroundLi, Y., Zhang, X., & Li, Y. (2019) · CNS Spectrums · doi:10.1017/s1092852919001603 · Cited by 33
“The NF-κB subunit p65 could downregulate Nrf2 activation either by cAMP-response element binding protein (CREBP) or histone deacetylase 3 (HDAC3)-related pathways.(86) Also, p65may decrease Nrf2 binding to its cognate DNA sequences and enhanceNrf2 ubiquitination.”
MethodHou, J., Zhuo, H., Chen, X., Cheng, J. R., Zheng, W., Zhong, M., & Cai, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.40338 · Cited by 33
“In response to numerous stimuli including tumor necrosis factor alpha (TNF-α) and bacterial lipopolysaccharide (LPS), NF-κB is activated and translocated into the nucleus from the cytoplasm, where it acts as a transcription factor to regulate its downstream target genes [35, 36, 41-43].”
BackgroundNRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting
Panda, H., Rowland, N. G., Krall, C. M., Bowman, B. M., Major, M. B., & Zolkind, P. (2025) · Oncogene · doi:10.1038/s41388-025-03560-4 · Cited by 39
Qin, S., & Hou, D. (2017) · Engineering · doi:10.1016/j.eng.2017.03.011 · Cited by 34
Najjar, R. S., Turner, C. G., Wong, B. J., & Feresin, R. G. (2021) · Nutrients · doi:10.3390/nu13020387 · Cited by 33
“Under conditions of inflammation and oxidative stress, NF-κB appears to bind 10-fold greater to CBP than Nrf2 as observed in HepG2 cells treated with 12-O-tetradecanoylphorbol-13-acetate (PMA; a protein kinase C activator) [247].”
The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
Bhandari, R., Kaur, J., Kaur, S., & Kuhad, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1887141 · Cited by 32
“erythroid2 – antioxidant responsive element (Nrf2-ARE) signaling [40].”
BackgroundZhang, D., Xiang, M., Jiang, Y., Wu, F., Chen, H., Sun, M., Zhang, L., Du, X., & Chen, L. (2022) · Foods · doi:10.3390/foods11111567 · Cited by 32
“Previous studies have demonstrated that TLR4 and Nrf2 pathways maintain a redox homeostasis and further modulate the key redox modulators by individually affecting various signaling cascades to interact with each other [43].”
BackgroundNopparat, C., Chantadul, V., Permpoonputtana, K., & Govitrapong, P. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.04.001 · Cited by 35
“and Nrf2 has been demonstrated that NF-κ B could interfere with Nrf2 at the transcriptional level via the withdrawal of CREB binding protein (CBP) from Nrf2 and via promoting the recruitment of histone deacetylase 3 (HDAC3), the co-repressor, to the antioxidant response element (ARE) region (Liu et al., 2008).”
BackgroundWafi, A. M., Yu, L., Gao, L., & Zucker, I. H. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00469.2019 · Cited by 31
“Previous data from the literature show that the prooxidant NF-kB and antioxidant Nrf2 transcription factors compete for binding to the nuclear creb binding protein (30); as such, both transcription factors are critical for regulating intracellular oxidative stress.”
BackgroundLipin proteins form homo- and hetero-oligomers
Liu, G., Qu, J. T., Carmack, A. E., Kim, H. B., Chen, C., Ren, H., Morris, A. J., Finck, B. N., & Harris, T. E. (2010) · Biochemical Journal · doi:10.1042/bj20100584 · Cited by 31
Oxidative stress and NRF2 signaling in kidney injury
Ng, C., Kim, I., Yanti, Y., & Kwak, M. (2024) · Toxicological Research · doi:10.1007/s43188-024-00272-x · Cited by 31
“Furthermore, NRF2 suppresses the transcriptional activity of NF-κB by competing for and diminishing the availability of cAMP-responsive-element-binding protein (CBP), a transcriptional co-activator for both NRF2 and NF-κB [108, 109].”
Najjar, R. S., Mu, S., & Feresin, R. G. (2022) · Antioxidants · doi:10.3390/antiox11040616 · Cited by 33
“However, under conditions of inflammation and oxidative stress, NF-κB appears to bind 10-fold greater to CBP than NRF2 as observed in HepG2 cells treated with 12-O-tetradecanoylphorbol-13-acetate [53].”
BackgroundSpeciale, A., Anwar, S., Ricciardi, E., Chirafisi, J., Saija, A., & Cimino, F. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.09.017 · Cited by 30
Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis
Lázaro, I., Oguiza, A., Recio, C., Lopez‐Sanz, L., Bernal, S., Egido, J., & Gómez‐Guerrero, C. (2017) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2016.10.003 · Cited by 32
Effects of Mycoplasmas on the Host Cell Signaling Pathways
Borchsenius, S. N., Vishnyakov, I. E., Chernova, O. A., Chernov, V. M., & Barlev, N. A. (2020) · Pathogens · doi:10.3390/pathogens9040308 · Cited by 29
“Importantly, forced overexpression of p300 was shown to alleviate the p53-mediated repression of RelA, emphasizing the fact that p300/CBP is likely a restricting influence for both transcription factors.”
BackgroundInfluentialGui, Y., Yang, Y., Xu, D., Tao, S., & Li, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118161 · Cited by 29
Cheung, K. L., Yu, S., Pan, Z., Ma, J., Wu, T.-Y., & Kong, A. T. (2011) · Chemical Research in Toxicology · doi:10.1021/tx1004369 · Cited by 29
NFkB and Nrf2 in esophageal epithelial barrier function
Chen, H. H., Yu, F., Li, W., Orlando, R. C., Shaheen, N. J., & Chen, X. L. (2013) · Tissue Barriers · doi:10.4161/tisb.27463 · Cited by 28
“p65 also represses the Nrf2 pathway at the transcriptional level through HDAC3 and CBP.(48) On the other hand, NFkB and Nrf2 both regulate a subset of target genes, including HO1, GCLC, Gαi2, and IL8.”
BackgroundSong, W., Yin, W., Ding, L., Gao, Y., Xu, J., Yang, Y., He, X., Gong, P., Wei, L., Chen, W., et al. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02485-z · Cited by 28
Perspectives on the Clinical Development of NRF2-Targeting Drugs
Lastra, D., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_381 · Cited by 29
Zhang, A., Zhang, J., Li, X., Zhang, H., Xiong, Y., Wang, Z., Zhao, N., Wang, F., & Luan, X. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02407-5 · Cited by 28
Izumi, Y., & Kōyama, Y. (2024) · Antioxidants · doi:10.3390/antiox13121527 · Cited by 31
Ito, T., Kimura, S., Seto, K., Warabi, E., Kawachi, Y., Shoda, J., Tabuchi, K., Yamagata, K., Hasegawa, S., Bukawa, H., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.12.002 · Cited by 27
“NFkB was found to compete with Nrf2 for the co-activator CREB binding protein (CBP) and to recruit histone deacetylase 3 (HDAC3), resulting in local hypoacetylation and the repression of Nrf2 signaling [24].”
BackgroundWang, P., Liu, Z., Zhang, X., Li, J., Sun, L., Ju, Z., Li, J., Chan, P., Liu, G., Zhang, W., et al. (2018) · Protein & Cell · doi:10.1007/s13238-018-0560-5 · Cited by 28
“Upon stimulations, the degradation of IκB releases NF-κB, which subsequently translocates to the nucleus to modulate genes for the maintenance of cellular homeostasis (Liu et al., 2008; Perkins, 2007).”
Luo, Z., Hu, Z., Bian, Y., Su, W., Li, X., Li, S., Wu, J., Li, S., Song, Y., Zheng, G., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00107 · Cited by 27
“Nrf2/NF-kB cross talk is also known to be a key pathway regulating downstream protein expression (Liu et al., 2008; Lee et al., 2009).”
BackgroundKostyuk, S. V., Porokhovnik, L. N., Ershova, E. S., Malinovskaya, E. M., Konkova, M. S., Kameneva, L. V., Dolgikh, O. А., Вейко, В. П., Писарев, В. М., Martynov, A. V., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1052413 · Cited by 27
“Seemingly, NF-κB can repress the NRF2 gene transcription by a mechanism connected with CREB: NF-κB competes with NRF2 for a transcription coactivator CREB-binding protein (a protein that binds to CREB) [66].”
BackgroundThe Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation
Martinez, R. M., Fattori, V., Saito, P., Pinto, I. C., Rodrigues, C. C. A., Melo, C. P. B., Bussmann, A. J. C., Staurengo‐Ferrari, L., Bezerra, J. R., Vignoli, J. A., et al. (2020) · Molecules · doi:10.3390/molecules25122953 · Cited by 30
“That mechanism dampens antioxidant response [54,55].”
BackgroundThomas, S. D., Jha, N. K., Sadek, B. S., & Ojha, S. K. (2022) · Pharmaceuticals · doi:10.3390/ph15050497 · Cited by 27
Lin, X.-L., Shi, Y., Cao, Y., Tan, X., Zeng, Y., Luo, S.-T., Li, Y., Li, Q., Xia, B., Fu, R.-G., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.960140 · Cited by 26
“The most well-established negative cross-talk between Nrf2 and NF-κB is a competitive combination with CBP–p300 complex (Liu et al., 2008).”
BackgroundNRF2 , a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer
Panieri, E., Telkoparan‐Akillilar, P., & Saso, L. (2022) · BioFactors · doi:10.1002/biof.1912 · Cited by 27
Rana, A. K., Kumar, R., Shukla, D. N., & Singh, D. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.004 · Cited by 26
Wang, Q., Dong, X., Li, N., Wang, Y., Guan, X., Lin, Y., Kang, J., Zhang, X., Zhang, Y., Li, X., et al. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.04.005 · Cited by 25
“SOD is a key endogenous antioxidant enzyme and is a component of first line defense system against reactive oxygen species (Alscher et al., 2002).”
InfluentialMa, Y., Qian, Y., Chen, Y., Ruan, X., Peng, X., Sun, Y., Zhang, J., Luo, J., Zhou, S., & Deng, C. (2023) · Journal of Periodontal Research · doi:10.1111/jre.13200 · Cited by 25
Hafizi, S., Silva, T. M. S., Meyer, J. H., Kiang, M., Houle, S., Remington, G. J., Prce, I., Wilson, A. A., Rusjan, P., Sailasuta, N., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0061-5 · Cited by 25
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma
Yen, C., & Hsiao, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113503 · Cited by 25
“Conversely, activated NRF2 suppresses NF-κB signaling [184,185].”
Mondal, D., Narwani, D., Notta, S., Ghaffar, D., Mardhekar, N. M., & Quadri, S. S. A. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.71 · Cited by 25
“Nuclear translocated NF-κB can directly inhibit Nrf-2 at the transcriptional level([194]) and vice versa([195]).”
BackgroundNrf2/ARE axis signalling in hepatocyte cellular death
Ghanim, B. Y., & Qinna, N. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07125-6 · Cited by 32
“However, it has been reported that persistent induction of Nrf2 through aggregation of p62 causes growth of hepatocellular carcinomas (HCCs) and could be worsened with Keap1 deficiency [49, 50].”
BackgroundInfluentialSubba, R., Ahmad, M. H., Ghosh, B., & Mondal, A. C. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174993 · Cited by 26
Alshammari, G. M., Abdelhalim, M. A. K., Al-Ayed, M. S., Al‐Harbi, L. N., & Yahya, M. A. (2022) · Nutrients · doi:10.3390/nu14163327 · Cited by 25
Metadata
- Authors
- Liu, G.-H., Qu, J., & Shen, X.
- Affiliations
- Chinese Academy of Sciences (CN)
- Corresponding author
- Shen, Xun
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 1783
- Issue
- 5
- Pages
- 713-727
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2113024198
- Cited by
- 697
- References
- 77
- Citations by year
- 2026: 54 · 2025: 45 · 2024: 51 · 2023: 47 · 2022: 68 · 2021: 51 · 2020: 59 · 2019: 59 · 2018: 47 · 2017: 38 · 2016: 32 · 2015: 33 · 2014: 15 · 2013: 28 · 2012: 13
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1904 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (30330250, 30570462)
- Shanghai Municipal Education Commission (E-04010)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- NF-κB p65, Nrf2, antioxidant response element, CBP, HDAC3, MafK, heme oxygenase-1, transcriptional repression, histone deacetylation, histone hypoacetylation, PKA phosphorylation, corepressor recruitment, anti-inflammatory signaling
- MeSH terms
- Histone Deacetylase 3, Antioxidants, Cell Line, Gene Expression Regulation, Histone Deacetylases, Humans, Transcription, Genetic, Trans-Activators, NF-kappa B, Response Elements, CREB-Binding Protein, MafK Transcription Factor, NF-E2-Related Factor 2, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review